Source:http://linkedlifedata.com/resource/pubmed/id/10953651
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
2000-9-28
|
pubmed:abstractText |
Nasal continuous positive airway pressure (n-CPAP) is an effective treatment for the obstructive sleep apnea syndrome (OSAS). It is currently regarded as the first line therapy for OSAS. The principal indication for n-CPAP treatment is daytime sleepiness. Nasal-CPAP improves daytime sleepiness dramatically in severe cases and the effect is objectively measurable with the multiple sleep latency test (MSLT). It is noteworthy that n-CPAP also improves symptoms, subjective daytime sleepiness, cognitive function, IQ, mood, quality of life and driving ability already in patients with mild sleep apnea with an apnea/hypopneaindex (AHI) between 5 and 15 per hour of sleep during overnight polysomnography. Although not yet 100% robust, there is clear evidence that patients with OSAS have an increased frequency of systemic hypertension. Some early and imperfect studies suggest that CPAP reduces cardiovascular and cerebrovascular outcomes; however unequivocal evidence that n-CPAP reduces mortality is still awaited. There is now good evidence that treatment with n-CPAP reduces the two- to sevenfold increased risk of road accidents of untreated patients with OSAS. In summary, there exists abundant evidence today that n-CPAP is an efficient therapy for symptomatic patients with the obstructive sleep apnea syndrome. A trial with n-CPAP is therefore justified in all symptomatic patients. Based on the large number of randomized controlled trials of n-CPAP a therapeutic trial is indicated even in only mildly symptomatic patients with OSAS. Nasal-CPAP use and outcomes of therapy can be improved by provision of an intensive CPAP-education and support program.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0040-5930
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
57
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
444-8
|
pubmed:dateRevised |
2008-2-12
|
pubmed:meshHeading |
pubmed-meshheading:10953651-Accidents, Traffic,
pubmed-meshheading:10953651-Disorders of Excessive Somnolence,
pubmed-meshheading:10953651-Humans,
pubmed-meshheading:10953651-Hypertension,
pubmed-meshheading:10953651-Positive-Pressure Respiration,
pubmed-meshheading:10953651-Randomized Controlled Trials as Topic,
pubmed-meshheading:10953651-Sleep Apnea, Obstructive,
pubmed-meshheading:10953651-Stroke,
pubmed-meshheading:10953651-Treatment Outcome
|
pubmed:year |
2000
|
pubmed:articleTitle |
[Effectiveness of nasal CPAP-treatment (continuous positive airway pressure)].
|
pubmed:affiliation |
Pneumologische Abteilung, Universitätskliniken, Inselspital, Bern. mgugger@insel.ch
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|